Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Big Data Reveals 1 Out Of 6 ER Visits In Q2 2017 Opioid Related

OM1
Posted on: 27 Nov 17

BOSTON, Nov. 27, 2017 /PRNewswire/ -- OM1, a leading AI health outcomes and data company focused on making healthcare more measured, precise and pre-emptive, today announced it has developed a prototype, using big data analytics, for tracking the opioid public health crisis in near real-time.

The OM1 opioid tracker leverages the OM1 Intelligent Data Cloud, which houses the largest, most extensively linked, clinically deep, representative and continually updated sets of healthcare information from the United States healthcare system. Data is assessed on a number of parameters including opioid-related emergency room (ER) visits and a range of important geographic, medical and other factors.

As most patients with symptoms of poisoning are transported to the ER for medical evaluation, this serves as an ideal screening portal to assess the magnitude, trends and potential clusters of this epidemic. Key initial findings, based on data assessments, include:

A sustained increase in opioid related ER visits since 2013; for example, in Q2 of 2017, 1 out of every 6 ER visits were opioid related

While the rate of opioid related ER visits increased across all ages during this time, the opioid epidemic is disproportionately impacting younger individuals. The fastest growing age segment is the 0-19 year age group, where rates increased from 10% in 2013 to 19% in Q1 of 2017.

The opioid epidemic is not an urban disease. While rates increased in all states, Montana is among a few states with the biggest changes in the proportion of opioid-related ER Visits since 2013.

"The opioid epidemic has reached alarming levels in the US, affecting the lives of millions of individuals and families. Big data analytics provide an enormous opportunity to be able to track and evaluate the crisis in near real time," said Vandana Menon, Vice President of Research at OM1. "With this prototype, we are hoping to contribute invaluable data that allows researchers and the healthcare community to gain a deeper, more comprehensive understanding of the magnitude, trends and clusters that are being most affected."

About OM1
OM1 is a leading healthcare technology and cognitive computing company focused on understanding the patient journey and the true results of healthcare. Leveraging big clinical data, outcomes measurement, and artificial intelligence technology, OM1 built the first intelligent data cloud for healthcare. OM1 delivers a scientifically robust and clinically meaningful approach to enable stakeholders across the healthcare ecosystem to improve outcomes with more precise information for better decision-making. Learn more at www.om1.com.  

CONTACT: Renne Hurley, 617-620-9571

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 27/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.